Wegovy is a GLP-1 receptor agonist medication, FDA-approved for chronic weight management and cardiovascular risk reduction in patients with obesity and overweight
GLP-1RAs and Aspiration Pneumonia Responding to the growing worries, in June 2023, a consensus-based guideline by The American Society of Anesthesiologists (ASA) considered holding GLP-1RAs prior to an endoscopic or surgical procedure to decrease the risk of aspiration pneumonia
Many people want to see big changes quickly, but real weight loss takes time
These symptoms are usually worst during the first few weeks and during each dose increase, then gradually improve as the body adapts
The peptide derives from a portion of a protein called Body Protection Compound, naturally found in human gastric juice
Probably MASH targeting in an overall cardiovascular and metabolic thinking is the most exciting part taking into consideration that now screening programs have open door for both, early primary prevention and treatment, and strong support in secondary prevention